Literature DB >> 24793420

Curcumin, a component of golden spice: from bedside to bench and back.

Sahdeo Prasad1, Subash C Gupta1, Amit K Tyagi1, Bharat B Aggarwal2.   

Abstract

Although the history of the golden spice turmeric (Curcuma longa) goes back thousands of years, it is only within the past century that we learned about the chemistry of its active component, curcumin. More than 6000 articles published within the past two decades have discussed the molecular basis for the antioxidant, anti-inflammatory, antibacterial, antiviral, antifungal, and anticancer activities assigned to this nutraceutical. Over sixty five clinical trials conducted on this molecules, have shed light on the role of curcumin in various chronic conditions, including autoimmune, cardiovascular, neurological, and psychological diseases, as well as diabetes and cancer. The current review provides an overview of the history, chemistry, analogs, and mechanism of action of curcumin. Published by Elsevier Inc.

Entities:  

Keywords:  Chronic diseases; Clinical trials; Curcumin; Curcumin analogs; Inflammation

Mesh:

Substances:

Year:  2014        PMID: 24793420     DOI: 10.1016/j.biotechadv.2014.04.004

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  140 in total

1.  The survival of patients with high grade glioma from different ethnic groups in South East England.

Authors:  T Ratneswaren; R M Jack; D Tataru; E A Davies
Journal:  J Neurooncol       Date:  2014-08-26       Impact factor: 4.130

Review 2.  Dietary factors in rheumatic autoimmune diseases: a recipe for therapy?

Authors:  Shani Dahan; Yahel Segal; Yehuda Shoenfeld
Journal:  Nat Rev Rheumatol       Date:  2017-04-13       Impact factor: 20.543

Review 3.  Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.

Authors:  Ajaikumar B Kunnumakkara; Devivasha Bordoloi; Ganesan Padmavathi; Javadi Monisha; Nand Kishor Roy; Sahdeo Prasad; Bharat B Aggarwal
Journal:  Br J Pharmacol       Date:  2016-10-21       Impact factor: 8.739

4.  Curcumin-loaded self-nanomicellizing solid dispersion system: part I: development, optimization, characterization, and oral bioavailability.

Authors:  Ankit Parikh; Krishna Kathawala; Yunmei Song; Xin-Fu Zhou; Sanjay Garg
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

5.  Theoretical investigation into the cooperativity effect between the intermolecular π∙π and H-bonding interactions in the curcumin∙cytosine∙H2O system.

Authors:  Jie Pan; Duan-Lin Cao; Fu-de Ren; Jian-Long Wang; Lu Yang
Journal:  J Mol Model       Date:  2018-09-28       Impact factor: 1.810

Review 6.  Heterologous production of curcuminoids.

Authors:  J L Rodrigues; K L J Prather; L D Kluskens; L R Rodrigues
Journal:  Microbiol Mol Biol Rev       Date:  2015-03       Impact factor: 11.056

Review 7.  Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer.

Authors:  Muzafar A Macha; Shiv Ram Krishn; Rahat Jahan; Kasturi Banerjee; Surinder K Batra; Maneesh Jain
Journal:  Cancer Treat Rev       Date:  2015-01-14       Impact factor: 12.111

8.  Curc-mPEG454, a PEGylated Curcumin Derivative, Improves Anti-inflammatory and Antioxidant Activities: a Comparative Study.

Authors:  Fei Cheng; Yuhe Chen; Zhu Zhan; Yu Liu; Peng Hu; Hong Ren; Huadong Tang; Mingli Peng
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

Review 9.  Curcumin: A Review of Its Effects on Epilepsy.

Authors:  Fatemeh Forouzanfar; Muhammed Majeed; Tannaz Jamialahmadi; Amirhosein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy.

Authors:  Bo Xiao; Xiaoying Si; Moon Kwon Han; Emilie Viennois; Mingzhen Zhang; Didier Merlin
Journal:  J Mater Chem B       Date:  2015-09-01       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.